Double Digit NASDAQ Stock Winners: EDSA, ZIVO, ARQQ

Following are major stock gainers on Nasdaq in Monday’s trading session:

Edesa Biotech, Inc. (NASDAQ:EDSA) was the active stock gainer on Monday and soared 102% to $11. after the company announced positive Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients. Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over standard of care.

An independent Data and Safety Monitoring Board concluded that “a clinically important efficacy signal” was detected and that the study “met its objective.” The DSMB recommended continuation of the study into a Phase 3 trial.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) stock surged 66% to $4.66 ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan.

 Arqit Quantum Inc (NASDAQ:ARQQ) moved up 36% to $24.94. Arqit Limited develops and offers quantum key distribution network. It offers QuantumCloud, an unbreakable software encryption keys, using satellite to deliver quantum information to data centers. The company uses the quantum properties of photons to create unique keys that can be shared between two parties in laser transmissions from a satellite. The company was incorporated in 2017 and is based in London, United Kingdom.